Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Junru Feng"'
Autor:
Ting Wang, Yingli Zhou, Zilong Zhou, Pinggen Zhang, Ronghui Yan, Linchong Sun, Wenhao Ma, Tong Zhang, Shengqi Shen, Haiying Liu, Hui Lu, Ling Ye, Junru Feng, Zhaolin Chen, Xiuying Zhong, Gao Wu, Yongping Cai, Weidong Jia, Ping Gao, Huafeng Zhang
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
The secretome of hepatocytes and hepatocellular carcinoma (HCC) cells can contribute to cancer progression. Here the authors show that PRSS35 inhibits HCC progression through proteolytic depletion of CXCL2 and subsequently decreased neutrophil recrui
Externí odkaz:
https://doaj.org/article/31287e0d0a02484996e857dc018da83a
Autor:
Yinghui Wang, Hui Lu, Linchong Sun, Xin Chen, Haoran Wei, Caixia Suo, Junru Feng, Mengqiu Yuan, Shengqi Shen, Weidong Jia, Ying Wang, Huafeng Zhang, Zijun Li, Xiuying Zhong, Ping Gao
Publikováno v:
Cell Death and Disease, Vol 12, Iss 10, Pp 1-13 (2021)
Abstract Metformin, the first-line drug for type II diabetes, has recently been considered an anticancer agent. However, the molecular target and underlying mechanism of metformin’s anti-cancer effects remain largely unclear. Herein, we report that
Externí odkaz:
https://doaj.org/article/29cf7987af48434eb91907903f7993ca
Autor:
Huafeng Zhang, Wei-Dong Jia, Ping Gao, Xiaozhang Zhang, Junru Feng, Lanhong Su, Yuhao Huangfu, Xiuying Zhong, Linchong Sun, Ying Shu, Shi-Ting Li, Haoran Wei, Shengqi Shen, Xiaoping He, Wenhao Ma, Zhaoyong Li, Songge Xing
DIS3-like 3′-5′ exoribonuclease 2 (DIS3L2) degrades aberrant RNAs, however, its function in tumorigenesis remains largely unexplored. Here, aberrant DIS3L2 expression promoted human hepatocellular carcinoma (HCC) progression via heterogeneous nuc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29a6fa879aa7a6b3bbb35ca94b3a6dd2
https://doi.org/10.1158/0008-5472.c.6510998.v1
https://doi.org/10.1158/0008-5472.c.6510998.v1
Autor:
Huafeng Zhang, Wei-Dong Jia, Ping Gao, Xiaozhang Zhang, Junru Feng, Lanhong Su, Yuhao Huangfu, Xiuying Zhong, Linchong Sun, Ying Shu, Shi-Ting Li, Haoran Wei, Shengqi Shen, Xiaoping He, Wenhao Ma, Zhaoyong Li, Songge Xing
Supplementary Figures: SF1, DIS3L2 promotes cell growth in Hep3B and HepG2 cells. SF2, DIS3L2 interacts hnRNP U in Hep3B and HepG2 hepatocellular carcinoma cells. SF3, DIS3L2 and hnRNP U promote exon 3b inclusion during pre-Rac1 splicing. SF14, The e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274e547efe9bbfdd19e159a716b1c182
https://doi.org/10.1158/0008-5472.22421708.v1
https://doi.org/10.1158/0008-5472.22421708.v1
Autor:
Ying Shu, Yijie Hao, Junru Feng, Haiying Liu, Shi‐ting Li, Jiaqian Feng, Zetan Jiang, Ling Ye, Yingli Zhou, Yuchen Sun, Zilong Zhou, Haoran Wei, Ping Gao, Huafeng Zhang, Linchong Sun
Publikováno v:
The EMBO Journal. 41
Phosphoglycerate dehydrogenase (PHGDH) is a key serine biosynthesis enzyme whose aberrant expression promotes various types of tumors. Recently, PHGDH has been found to have some non-canonical functions beyond serine biosynthesis, but its specific me
Autor:
Junru Feng, Hui Lu, Wenhao Ma, Wenjing Tian, Zhuan Lu, Hongying Yang, Yongping Cai, Pengfei Cai, Yuchen Sun, Zilong Zhou, Jiaqian Feng, Jiazhong Deng, Ying Shu, Kun Qu, Weidong Jia, Ping Gao, Huafeng Zhang
Publikováno v:
Proteincell. 13(11)
Metformin is currently a strong candidate anti-tumor agent in multiple cancers. However, its anti-tumor effectiveness varies among different cancers or subpopulations, potentially due to tumor heterogeneity. It thus remains unclear which hepatocellul
Autor:
Junru Feng, Xiaolin Zhang
Publikováno v:
Applied Economics and Finance. 9:1
The mobile game market is now gradually forming a unique ecological industry chain. Game parties are beginning to look beyond the game experience and focus on building mature game IPs. By creating specific IP to drive the game’s peripheral revenue,
Autor:
Qian Jing, Qing Shao, Hui Liu, Zhaoyun Liu, Yanqi Li, Jing Li, Junru Feng, Rong Fu, Jin Chen, Honglei Wang
Publikováno v:
Journal of Investigative Medicine. 67:39-47
Multiple myeloma (MM) is characterized by the proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraproteins (M proteins). Everolimus works similarly to sirolimus as a mammalian target of rapamycin (mTOR) inhibitor.
Autor:
Shengqi Shen, Huafeng Zhang, Mengqiu Yuan, Haoran Wei, Ying Wang, Ping Gao, Zi-Jun Li, Junru Feng, Hui Lu, Yinghui Wang, Xin Chen, Linchong Sun, Weidong Jia, Caixia Suo, X.C. Zhong
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 12, Iss 10, Pp 1-13 (2021)
Cell Death and Disease, Vol 12, Iss 10, Pp 1-13 (2021)
Metformin, the first-line drug for type II diabetes, has recently been considered an anticancer agent. However, the molecular target and underlying mechanism of metformin’s anti-cancer effects remain largely unclear. Herein, we report that metformi
Autor:
Ping Gao, Wenhao Ma, Shi-Ting Li, Yuhao Huangfu, Linchong Sun, X.C. Zhong, Zhaoyong Li, Weidong Jia, Xiaozhang Zhang, Junru Feng, Shengqi Shen, Songge Xing, Xiaoping He, Ying Shu, Haoran Wei, Huafeng Zhang, Lanhong Su
Publikováno v:
Cancer research. 79(19)
DIS3-like 3′-5′ exoribonuclease 2 (DIS3L2) degrades aberrant RNAs, however, its function in tumorigenesis remains largely unexplored. Here, aberrant DIS3L2 expression promoted human hepatocellular carcinoma (HCC) progression via heterogeneous nuc